STABLE FORMULATIONS OF CYTOMEGALOVIRUS

The present invention relates to stable formulations of a cytomegalovirus (CMV) comprising for example, a genetically modified CMV that is conditionally replication defective, a buffer, alkali or alkaline salt, a sugar, a cellulose derivative and optionally a polyol. La présente invention concerne d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BLUE, Jeffrey Thomas, MEDI, Muneeswara Babu, CHEN, Lorenzo, GREEN-TREXLER, Erin, DAVIS, Harrison Bradford, ISOPI, Lynne Ann, PIXLEY, Heidi Joanne
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to stable formulations of a cytomegalovirus (CMV) comprising for example, a genetically modified CMV that is conditionally replication defective, a buffer, alkali or alkaline salt, a sugar, a cellulose derivative and optionally a polyol. La présente invention concerne des formulations stables d'un cytomégalovirus (CMV) comprenant par exemple un CMV génétiquement modifié qui manque de réplication conditionnelle, un tampon, un alcali ou un sel alcalin, un sucre, un dérivé de cellulose et éventuellement un polyol.